The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...
AeroDel’s founders, Zahir Jaffer, Shradha Sangwai and K.K.Suraj Rajan, have one common denominator: asthma. This led them to ...
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...
Stockhead on MSN
Ageing Aussies are driving the next wave of healthcare growth
Longer lives are creating new healthcare demands, opening opportunities across stroke, lung, memory and sexual health. ...
UK government drives forward its 150-day clinical trial target: United Kingdom Friday, April 17, 2026, 09:00 Hrs [IST] NHS patients will be able to access life-changing new treatm ...
Zacks Investment Research on MSN
SNY & REGN's Dupixent gets EU approval for pediatric use in urticaria
Sanofi SNY and its partner Regeneron Pharmaceuticals REGN announced that the European Commission (EC) has approved the ...
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria. Approval in CSU for children two to ...
Severe non-communicable diseases (NCDs) such as type 1 diabetes mellitus (T1DM), sickle cell disease (SCD), thalassaemia and ...
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU) ...
The executive order will open the door for more research into the psychedelic drug ibogaine, sources told CBS News earlier ...
The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results